Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
NCT00548171
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
203
Enrollment
INDUSTRY
Sponsor class
Conditions
Acellular Pertussis
Tetanus
Diphtheria
Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions
BIOLOGICAL:
Boostrix™
Sponsor
GlaxoSmithKline